Fig. 1From: Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancerMET variations in the pan-cancer study, MSK MetTropism (MSK, Cell 2021), of the cBioPortal database. A MET variations in the pan-cancer study. B MET putative driver variations in the pan-cancer study. C MET fusions in the pan-cancer study. D. MET putative driver fusions in the pan-cancer studyBack to article page